Lecturas recomendadas comentadas


2022

septiembre

  • Low-Dose Subcutaneous or Intravenous Monoclonal Antibody to Prevent Malaria
  • Revisado por: Antoni Soriano Arandes
  • Grupo de trabajo: Patología Importada
  • Referencia: Wu RL, Idris AH, Berkowitz NM, Happe M, Gaudinski MR, Buettner C, et al. Low-Dose Subcutaneous or Intravenous Monoclonal Antibody to Prevent Malaria. N Engl J Med. 2022 Aug 4; 387(5):397-407. doi: 10.1056/NEJMoa2203067
  • Descargar:   PDF

julio

  • Extended Infusion of Beta-Lactams Is Associated With Improved Outcomes in Pediatric Patients.
  • Revisado por: Ana Isabel Menasalvas Ruiz
  • Grupo de trabajo: Infecciones relacionadas con la asistencia sanitaria
  • Referencia: Zembles TN, Schortemeyer R, Kuhn EM, et al. Extended Infusion of Beta-Lactams Is Associated With Improved Outcomes in Pediatric Patients. J Pediatr Pharmacol Ther. 2021; 26:187-193. doi: 10.5863/1551-6776-26.2.187.
  • Descargar:   PDF

junio

  • Evidence of Artemisinin-Resistant Malaria in Africa
  • Revisado por: David Torres y Luis M. Prieto
  • Grupo de trabajo: Patología Importada
  • Referencia: Balikagala B, Fukuda N, Ikeda M, et al. Evidence of Artemisinin-Resistant Malaria in Africa. N Engl J Med. 2021;385:1163-71
  • Descargar:   PDF

mayo

  • Urinary Proadrenomedullin and Disease Severity in Children With Suspected Community-acquired Pneumonia
  • Revisado por: José Antonio Couceiro Gianzo
  • Grupo de trabajo: Infecciones Respiratorias
  • Referencia: Florin TA, Ambroggio L, Shah SS, Ruddy RM, Nylen ES, Balmert L. Urinary Proadrenome-dullin and Disease Severity in Children With Suspected Community-acquired Pneumonia. Pediatr Infect Dis J 2021 Dec1;40(12):1070–1075.
  • Descargar:   PDF

abril

  • Mortality Associated With Influenza and Respiratory Syncytial Virus in the US, 1999-2018
  • Revisado por: Enrique Otheo
  • Grupo de trabajo: Infecciones Respiratorias
  • Referencia: Hansen CL, Chaves SS, Demont C, Viboud C. Mortality Associated With Influenza and Respiratory Syncytial Virus in the US, 1999-2018. JAMA Netw Open. 2022 Feb; 5(2):e220527. doi: 10.1001/jamanetworkopen.2022.0527.
  • Descargar:   PDF
  • Duration of Antibiotic Therapy in Neonatal Gram-negative Bacterial Sepsis-10 Days Versus 14 Days: A Randomized Controlled Trial
  • Revisado por: Laura Martín Pedraz
  • Grupo de trabajo: Infecciones relacionadas con la asistencia sanitaria
  • Referencia: Fursule A, Thakur A, Garg P, Kler N. Duration of Antibiotic Therapy in Neonatal Gram-negative Bacterial Sepsis-10 Days Versus 14 Days: A Randomized Controlled Trial. Pediatr Infect Dis J 2022. 41;2:156-160
  • Descargar:   PDF

marzo

  • Prospective, historically controlled study to evaluate the efficacy and safety of a new paediatric formulation of nifurtimox in children aged 0 to 17 years with Chagas disease one year after treatment (CHICO)
  • Revisado por: María José Muñoz Vilches
  • Grupo de trabajo: Patología Importada
  • Referencia: Jaime AltchehI, Luis CastroI, Juan C. Dib, et al. Prospective, historically controlled study to evaluate the efficacy and safety of a new paediatric formulation of nifurtimox in children aged 0 to 17 years with Chagas disease one year after treatment (CHICO). PLOS Neglected Tropical Diseases https://doi.org/10.1371/journal.pntd.0008912 January 7, 2021
  • Descargar:   PDF

febrero

  • Antibiotic Therapies for Clostridioides difficile Infection in Children
  • Revisado por: Walter Alfredo Goycochea Valdivia
  • Grupo de trabajo: Infecciones relacionadas con la asistencia sanitaria
  • Referencia: Gonzales-Luna AJ, Carlson TJ, Garey KW. Antibiotic Therapies for Clostridioides difficile Infection in Children. J Pediatric Infect Dis Soc. 2021 Nov 17;10(Supplement_3):S52-S57.
  • Descargar:   PDF
  • Ten Years of National Seasonal Surveillance for Severe Complications of Influenza in Australian Children
  • Revisado por: Marta Cruz Cañete
  • Grupo de trabajo: Infecciones Respiratorias
  • Referencia: Teutsch SM, Zurynski YA, Nunez C, et al. Australian Paediatric Surveillance Unit. Ten Years of National Seasonal Surveillance for Severe Complications of Influenza in Australian Children. Pediatr Infect Dis J 2021; 40:191-198
  • Descargar:   PDF

enero

  • Severity of Illness Caused by Severe Acute Respiratory Syndrome Coronavirus 2 Variants of Concern in Children: A Single-Center Retrospective Cohort Study
  • Revisado por: Alfredo Tagarro
  • Grupo de trabajo: Infecciones Respiratorias
  • Referencia: Edward PR, Ramon-Redondo R, E. Reyna M, et al. Severity of Illness Caused by Severe Acute Respiratory Syndrome Coronavirus 2 Variants of Concern in Children: A Single-Center Retrospective Cohort Study. medRxiv 2021.10.23.21265402; doi:https://doi.org/10.1101/2021.10.23.21265402
  • Descargar:   PDF